Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy

Current Cardiology Reports

Volumn 9, Issue 1, 2007, Pages 51-56

  O'Hanlon, Rory ^a   Assomull, Ravi G ^a   Prasad, Sanjay K ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; ECG ABNORMALITY; ELECTROCARDIOGRAM; GENE MUTATION; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IN VIVO STUDY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL RESEARCH; MITRAL VALVE REGURGITATION; MUSCLE RESECTION; NUCLEAR MAGNETIC RESONANCE; PATIENT SELECTION; PHENOTYPE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TISSUE CHARACTERIZATION;

CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; ENDOMYOCARDIAL FIBROSIS; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; RISK FACTORS; STROKE VOLUME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 34047253725     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-007-0010-0     Document Type: Review

References (31)

1. Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
2. Marian AJ, Roberts R: Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995, 92:1336-1347.
3. Roberts R, Sigwart U: New concepts in hypertrophic cardiomyopathy, part I. Circulation 2001, 104-2113-2116.
4. Maron BJ, McKenna WJ, Danielson GK, et al.: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003, 42:1687-1713.
5. Maron BJ, Gardin JM, Flack JM, et al.: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in a CARDIA study. Circulation 1995, 92:785-789.
6. Spirito P, Bellone P, Harris KM, et al.: Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000, 342:1778-1785.
7. Elliott PM, Poloniecki J, Dickie S, et al.: Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000, 36:2212-2218.
8. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:2125-2132.
9. Braunwald E, Seidman CE, Sigwart U: Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation 2002, 106:1312-1316.
10. Rickets C, Wilke NM, Jerosch-Herold M, et al.: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855-861.
11. Moon JCC, Fisher NG, McKenna WJ, et al.: Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography. Heart 2004, 90:645-649.
12. Eriksson MJ, Sonnenberg B, Woo A, et al.: Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 39:638-645.
13. Grothues F, Smith GC, Moon JC, et al.: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29-34.
14. Schulz-Menger J, Abdel-Aty H, Busjahn A, et al.: Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2006, 8:741-746.
15. Maron BJ, Wolfson JK, Epstein SE, et al.: Intramural small vessel coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986, 8:545-557.
16. Moon JC, Reed E, Sheppard MN, et al.: The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 43:2260-2264.
17. Choudhury L, Mahrholdt H, Wagner A, et al.: Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 40:2156-2164.
18. Moon JC, Mogensen J, Elliott PM, et al.: Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 2005, 91:1036-1040.
19. Teraoka K, Hirano M, Ookubo H, et al.: Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 2004, 22:155-161.
20. Harris KM, Spirito P, Maron MS, et al.: Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006, 114:216-225.
21. Mogensen J, Murphy RT, Shaw T, et al.: Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004, 44:2033-2040.
22. Ennis DB, Epstein FH, Kellman P, et al.: Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging. Magn Reson Med 2003, 50:638-642.
23. van Dockum WG, Beek AM, ten Cate Fj, et al.: Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2005, 111:2503-2508.
24. Corrado D, Basso C, Schiavon M, et al.: Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998, 339:364-369.
25. Maron BJ, Mathenge R, Casey SA, et al.: Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. J Am Coll Cardiol 1999, 33:1590-1595.
26. Moon JC, Sheppard M, Reed E, et al.: The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006, 8:479-482.
27. Maceira AM, Joshi J, Prasad SK, et al.: Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005, 111:186-193.
28. Maron BJ: Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986, 7:190-203.
29. Bellenger NG, Gatehouse PD, Rajappan K, et al.: Left ventricular quantification in heart failure by cardiovascular MR using prospective respiratory navigator gating: comparison with breath-hold acquisition. J Magn Reson Imaging 2000, 11:411-417.
30. Pan L, Stuber M, Kraitchman DL, et al.: Real-time imaging of regional myocardial function using fast-SENC. Magn Reson Med 2006, 55:386-395.
31. Senthil V, Chen SN, Tysbouleva N, et al.: Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 2005, 97:285-292.